Aldoxorubicin: Additional Phase II data

Data from 21 evaluable patients with unresectable GBM who progressed following surgery, radiation and

Read the full 147 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE